Search clinical trials for: Oxybutynin 3% gel

Total 10283 results

Asmaa Abdallah Ahmed Hussein
Cairo University

Completed

Designed Protocol of Care for Postpartum Perineal Trauma

Perineal Injury

Egypt
Alcon Research

Completed

In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients

Dry Eye Syndrome
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
University of Nebraska

Completed

Impact of Oral Hygiene Gels on Peri-implant Mucositis

Mucositis

United States
Topokine Therapeutics, Inc.

Suspended

Safety and Feasibility Study of XAF5 Gel for Reduction of Submental Fat

Excess Submental Fat ("Double Chin")
Kamedis Ltd.

Unknown

Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis (kam1403)

Radiation Dermatitis

Israel
DermBiont, Inc.

Active, not recruiting

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

Tinea Pedis

United States
Spherium Biomed
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Hospital... and other collaborators

Completed

Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation (MUCOMEL)

Oral Mucositis

Spain
Bayer

Completed

Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

Overactive Bladder

United States
Alza Corporation, DE, USA

Completed

Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder

Urinary Incontinence
Universidad de Valparaiso
Uro Medical Corporation

Enrolling by invitation

Effectiveness of Oral Boldo in Women With Overactive Bladder

Urinary Bladder, Overactive

Chile
Watson Pharmaceuticals

Completed

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Detrusor Hyperreflexia

United States
University of California, Davis

Recruiting

Oxybutynin for Post-surgical Bladder Pain and Urgency

Overactive Bladder Syndrome | Neuropathic Bladder

United States
University of Nairobi
Consortium for Advanced Research Training in Africa (CARTA); Innovix Pharma...

Completed

Omega-3 Supplementation and Depression Clinical Trial

Depressive Symptoms

Kenya
Allergan

Completed

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial

Overactive Bladder

United States
Janssen-Cilag Ltd.,Thailand

Terminated

Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity (RONDO)

Detrusor Function, Overactive

Thailand
Astellas Scientific & Medical Affairs, Inc.

Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) (PERSPECTIVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Canada
Population Council

Completed

Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women

HIV Infection

United States
Alza Corporation, DE, USA

Completed

A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence

Urinary Incontinence
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants

Urinary Bladder, Overactive
B. Braun Ltd. Centre of Excellence Infection Control

Terminated

HM242-Gel vs Comparator

Venous Leg Ulcer

Czechia, Slovakia
Bausch Health Americas, Inc.

Completed

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Acne

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

Acne Vulgaris | Androgenetic Alopecia

United States
Galderma R&D

Completed

Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment

Actinic Keratosis

Taiwan
Peplin

Completed

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
Duramed Research

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

Overactive Bladder

United States, Canada
Korea University
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Completed

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Actinic Keratosis

Korea, Republic of
Nutravalia
Slb Pharma

Completed

Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers

Overweight and Obesity

France
Galderma R&D

Completed

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris (FREE)

Acne

Canada
Xinnate AB
Region Skane

Completed

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Blister | Epidermolysis Bullosa | Wound of Skin | Varicose Ulcer of Lower Limb

Sweden
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.

Urination Disorders
LEO Pharma

Terminated

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

Actinic Keratosis | Squamous Cell Carcinoma

United States, Spain, Canada, Germany, France, United Kingdom
LEO Pharma

Completed

Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

Actinic Keratosis

United States
Medical University of Vienna

Completed

Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Actinic Keratosis

United States
Chang Gung Memorial Hospital

Unknown

Silicone Gel to Improve Scar in Microtia Patients

Scar | Microtia

Taiwan
Kalypsys, Inc.

Completed

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

Neuropathic Pain | Herpes Zoster | Postherpetic Neuralgia | Shingles

United States
Orient Pharma Co., Ltd.

Completed

A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease

Sialorrhoea

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
Novan, Inc.

Completed

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
UroGen Pharma Ltd.

Withdrawn

Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") (INTIMO2)

Overactive Bladder

Israel
Bausch Health Americas, Inc.

Completed

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Acne Vulgaris

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

Actinic Keratosis

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Actinic Keratosis

Germany
Brooke Army Medical Center

Completed

Comparison of Patient Satisfaction Using Heated Versus Room Temperature Ultrasound Gel (HUGS)

Ultrasound
Peplin

Completed

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Actinic Keratoses

United States, Australia
Università degli Studi dell'Insubria

Unknown

Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis

Vaginitis

Italy
US Department of Veterans Affairs

Completed

Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

Overactive Bladder | Parkinson's Disease

United States

3

Subscribe